Nevertheless, the effect on breast cancer varies according to subtype, as it decreases the risk of developing hormone-receptor-positive subtypes of breast cancer mainly the HR+ and Ki-67 subtypes [110]. This evidence concerns the gene MKI67 and breast cancer.